World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
29699
World Ranking
9017
National Ranking
4644

Marc E. Lippman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Marc E. Lippman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 298 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Marc E. Lippman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Marc E. Lippman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Marc E. Lippman is affiliated with the National Institutes of Health in the United States. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology, with a focus on oncology and cancer-related fields. The scientist's work includes molecular biology, cancer research, pulmonary and respiratory medicine, and genetics.

Several main topics characterize the body of their research: cancer immunotherapy and biomarkers, cancer cells and metastasis, cancer genomics and diagnostics, advanced glycation end products research, cancer, stress, anesthesia, and immune response, chemotherapy-induced cardiotoxicity and mitigation, and estrogen and related hormone effects.

Marc E. Lippman has published extensively, and notable recent papers include:

  • "Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies" (2021, Breast Cancer Research and Treatment)
  • "The Major Pre- and Postmenopausal Estrogens Play Opposing Roles in Obesity-Driven Mammary Inflammation and Breast Cancer Development" (2020, Cell Metabolism)
  • "Evaluating the impact of age on immune checkpoint therapy biomarkers" (2021, Cell Reports)
  • "Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis" (2021, Breast Cancer Research and Treatment)
  • "RAC1 plays an essential role in estrogen receptor alpha function in breast cancer cells" (2021, Oncogene)

Frequent co-authors collaborating with Marc E. Lippman include:

  • Barry I. Hudson
  • Nanette H. Bishopric
  • Erik T. Goka
  • Claudine Isaacs
  • Utsav Sharma

The scientist's research has been published in a variety of venues, with multiple publications in:

  • Cancer Research
  • Breast Cancer Research and Treatment
  • Cell Reports
  • Molecular Cancer Therapeutics
  • Journal of Clinical Oncology

Marc E. Lippman has been recognized as a member of the Association of American Physicians. Their research contributes broadly across medicine and molecular biology disciplines, focusing particularly on oncology and breast cancer biology, hormone interactions, immune responses, and therapy-related side effects.

Best Publications

  • Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells

    Cornelius Knabbe;Marc E. Lippman;Lalage M. Wakefield;Kathleen C. Flanders

  • The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.

    Marc Lippman;Gall Bolan;Karen Huff

  • Estrogenic Regulation of Growth and Polypeptide Growth Factor Secretion in Human Breast Carcinoma

    Robert B. Dickson;Marc E. Lippman

  • Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.

    Erik W. Thompson;Soonmyoung Paik;Nils Brünner;Connie L. Sommers

  • Mechanism of action of glucocorticoids.

    E.Brad Thompson;Marc E. Lippman

  • Establishment and Characterization of Three New Continuous Cell Lines Derived from Human Breast Carcinomas

    Linda W. Engel;Nathaniel A. Young;Tommie Sue Tralka;Marc E. Lippman

  • BRCA1 Sequence Analysis in Women at High Risk for Susceptibility Mutations: Risk Factor Analysis and Implications for Genetic Testing

    Donna Shattuck-Eidens;Arnold Oliphant;Melody McClure;Celeste McBride

  • Autocrine and paracrine growth regulation of human breast cancer

    Marc E. Lippman;Robert B. Dickson;Susan Bates;Cornelius Knabbe

  • Oestrogen-responsive human breast cancer in long term tissue culture.

    Marc E. Lippman;Gail Bolan

  • Characterization of estrogen responsive transforming activity in human breast cancer cell lines

    Robert B. Dickson;Susan E. Bates;Mary E. McManaway;Marc E. Lippman

  • Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance

    Susan E. Bates;Nancy E. Davidson;Eva M. Valverius;Carl E. Freter

  • Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.

    Lawrence Tamarkin;Michael Cohen;David Roselle;Cheryl Reichert

  • Induction of Epidermal Growth Factor-Related Polypeptides by 17β-Estradiol in MCF-7 Human Breast Cancer Cells

    R. B. Dickson;K. K. Huff;E. M. Spencer;Marc E. Lippman

  • Regulation of the estrogen receptor in MCF-7 cells by estradiol.

    Miguel Saceda;Marc E. Lippman;Pierre Chambon;Ralph L. Lindsey

  • Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth

    Robert B. Dickson;Mary E. McManaway;Marc E. Lippman

  • Epidermal Growth Factor Receptor Gene Expression in Estrogen Receptor-Positive and Negative Human Breast Cancer Cell Lines

    Nancy E. Davidson;Edward P. Gelmann;Marc E. Lippman;Robert B. Dickson

  • Neoadjuvant Chemotherapy in the Combined Modality Approach of Locally Advanced Nonmetastatic Breast Cancer

    Sandra M. Swain;Richard A. Sorace;Caroline S. Bagley;David N. Danforth

  • Role of pineal gland in aetiology and treatment of breast cancer.

    Michael Cohen;Marc Lippman;Bruce Chabner

  • Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines.

    D. A. Bronzert;P. Pantazis;H. N. Antoniades;A. Kasid

  • Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters.

    Sandra M. Levy;Ronald B. Herberman;Annette M. Maluish;Bernadene Schlien

Frequent Co-Authors

Erik W. Thompson
Erik W. Thompson Queensland University of Technology
Susan E. Bates
Susan E. Bates Columbia University
E. Brad Thompson
E. Brad Thompson The University of Texas Medical Branch at Galveston
Robert Clarke
Robert Clarke University of Oxford
Edward P. Gelmann
Edward P. Gelmann University of Arizona
Bruce A. Chabner
Bruce A. Chabner Harvard University
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Sandra M. Swain
Sandra M. Swain Georgetown University Medical Center
Richard Simon
Richard Simon University of Michigan–Ann Arbor
Michael D. Johnson
Michael D. Johnson Georgetown University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but seeking flexible study options, various accredited online programs offer a strong foundation for advancing your healthcare career. Moving beyond the traditional MD route, programs like the top online mha programs that are cahme accredited provide specialized training in healthcare administration, suitable for those interested in leadership roles.

Registered nurses looking to expand their skills may consider online rn to bsn programs without clinicals, allowing them to earn a bachelor’s degree in nursing from home while maintaining their current job. For those aiming higher, a Doctor of Nursing Practice can elevate clinical expertise or transition into advanced practice or executive positions.

For a faster route, the fastest dnp online program option can help you earn your doctorate in less time, while the cheapest dnp program ensures financial flexibility. These online pathways broaden access, providing working professionals and aspiring healthcare leaders new ways to grow in the medical field.

Best Scientists Citing Marc E. Lippman

Recently Published Articles